AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding AbCellera Biologics Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 162 | 190 | +28 |
| Shares | 118.1M | 121.8M | +3.68M (+3.1%) |
| Value | $1.26B | $1.21B | −$54.9M (−4.3%) |
New holders (43)
Institutions that held AbCellera Biologics Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (15)
Institutions that held AbCellera Biologics Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Allianz Asset Management GmbH | 10,822,530 | $115.3M |
| Alyeska Investment Group, L.P. | 746,652 | $7.95M |
| Temasek Holdings (Private) Ltd | 281,729 | $3.00M |
| Voloridge Investment Management, LLC | 196,406 | $2.09M |
| Trexquant Investment LP | 173,864 | $1.85M |
| Gsa Capital Partners LLP | 68,466 | $729.0K |
| UBS Asset Management Americas Inc | 31,998 | $340.8K |
| DCVC Bio GP, LLC | 29,411 | $313.0K |
| Moloney Securities Asset Management, LLC | 15,800 | $168.0K |
| C M Bidwell & Associates Ltd | 11,625 | $124.0K |
| Boothbay Fund Management, LLC | 10,793 | $115.0K |
| Geneos Wealth Management Inc. | 10,087 | $107.0K |
| Worth Asset Management, LLC | 3,750 | $40.0K |
| Rockefeller Capital Management L.P. | 500 | $5.00K |
| Spire Wealth Management | 55 | $1.00K |